These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An introduction to psychedelic neuroscience. Calvey T; Howells FM Prog Brain Res; 2018; 242():1-23. PubMed ID: 30471677 [TBL] [Abstract][Full Text] [Related]
3. Sustained effects of single doses of classical psychedelics in humans. Knudsen GM Neuropsychopharmacology; 2023 Jan; 48(1):145-150. PubMed ID: 35729252 [TBL] [Abstract][Full Text] [Related]
4. The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Vollenweider FX; Kometer M Nat Rev Neurosci; 2010 Sep; 11(9):642-51. PubMed ID: 20717121 [TBL] [Abstract][Full Text] [Related]
5. Beating pain with psychedelics: Matter over mind? Elman I; Pustilnik A; Borsook D Neurosci Biobehav Rev; 2022 Mar; 134():104482. PubMed ID: 34922987 [TBL] [Abstract][Full Text] [Related]
6. Psychedelics and music: neuroscience and therapeutic implications. Barrett FS; Preller KH; Kaelen M Int Rev Psychiatry; 2018 Aug; 30(4):350-362. PubMed ID: 30240282 [TBL] [Abstract][Full Text] [Related]
7. Psychedelics and Other Psychoplastogens for Treating Mental Illness. Vargas MV; Meyer R; Avanes AA; Rus M; Olson DE Front Psychiatry; 2021; 12():727117. PubMed ID: 34671279 [TBL] [Abstract][Full Text] [Related]
8. More than meets the eye: The role of sensory dimensions in psychedelic brain dynamics, experience, and therapeutics. Aqil M; Roseman L Neuropharmacology; 2023 Feb; 223():109300. PubMed ID: 36334767 [TBL] [Abstract][Full Text] [Related]
9. Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Johnson MW; Hendricks PS; Barrett FS; Griffiths RR Pharmacol Ther; 2019 May; 197():83-102. PubMed ID: 30521880 [TBL] [Abstract][Full Text] [Related]
10. The renaissance in psychedelic research: What do preclinical models have to offer. Murnane KS Prog Brain Res; 2018; 242():25-67. PubMed ID: 30471682 [TBL] [Abstract][Full Text] [Related]
11. Towards an understanding of psychedelic-induced neuroplasticity. Calder AE; Hasler G Neuropsychopharmacology; 2023 Jan; 48(1):104-112. PubMed ID: 36123427 [TBL] [Abstract][Full Text] [Related]
12. Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms. Garcia-Romeu A; Darcy S; Jackson H; White T; Rosenberg P Curr Top Behav Neurosci; 2022; 56():287-317. PubMed ID: 34734390 [TBL] [Abstract][Full Text] [Related]
13. Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology. Kelly DF; Heinzerling K; Sharma A; Gowrinathan S; Sergi K; Mallari RJ Neurosurgery; 2023 Apr; 92(4):680-694. PubMed ID: 36512813 [TBL] [Abstract][Full Text] [Related]
14. Human behavioral pharmacology of psychedelics. Strickland JC; Johnson MW Adv Pharmacol; 2022; 93():105-132. PubMed ID: 35341564 [TBL] [Abstract][Full Text] [Related]
15. Catalysts for change: the cellular neurobiology of psychedelics. Banks MI; Zahid Z; Jones NT; Sultan ZW; Wenthur CJ Mol Biol Cell; 2021 Jun; 32(12):1135-1144. PubMed ID: 34043427 [TBL] [Abstract][Full Text] [Related]